发明名称 Ccr4 antagonist and medical use thereof
摘要 A compound of formula (I) or a salt thereof, and medical use thereof (the symbols in the formula are as described in the specification). The compound of formula (I) has CCR4 antagonistic activity, and therefore is useful as a preventive and/or therapeutic agent for diseases associated with CCR4, i.e., CCR4-mediated diseases such as inflammatory and/or allergic diseases [e.g., systemic inflammatory response syndrome (SIRS), anaphylaxis or anaphylaxis-like reaction, allergic vasculitis, reject reaction for graft organ, hepatitis, nephritis, nephrosis, pancreatitis, rhinitis, arthritis, inflammatory ocular diseases, inflammatory bowel diseases, diseases in cerebro and/or circulatory system, respiratory diseases, dermatic diseases, autoimmune diseases, etc.], and the like.
申请公布号 US2006004010(A1) 申请公布日期 2006.01.05
申请号 US20050520660 申请日期 2005.01.10
申请人 HABASHITA HIROMU;KOKUBO MASAYA;SHIBAYAMA SHIRO;TADA HIDEAKI;SAGAWA KENJI 发明人 HABASHITA HIROMU;KOKUBO MASAYA;SHIBAYAMA SHIRO;TADA HIDEAKI;SAGAWA KENJI
分类号 A61K31/4965;A61K31/497;A61K31/498;A61K31/506;A61K31/55;A61P1/04;A61P1/16;A61P1/18;A61P3/10;A61P9/10;A61P11/00;A61P11/06;A61P13/12;A61P17/00;A61P17/06;A61P19/02;A61P25/00;A61P27/02;A61P27/16;A61P29/00;A61P31/12;A61P31/18;A61P35/00;A61P35/02;A61P37/00;A61P37/06;A61P37/08;A61P43/00;C07D241/22;C07D241/26;C07D241/44;C07D401/12;C07D409/12 主分类号 A61K31/4965
代理机构 代理人
主权项
地址